جميع الدراسات
نشط غير مجندالمرحلة 3تدخلي

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

This study, called RAISE-XT, is for existing participants in a trial looking at a medicine called zilucoplan. It focuses on people living with a muscle weakness condition known as generalized myasthenia gravis (gMG). The main goal is to understand how well zilucoplan works and how safe it is over a longer period. By continuing to follow people who have already taken the medicine, researchers can gather important information about its long-term effects. This helps us learn more about zilucoplan as a treatment option for gMG, hoping to improve care for those with the condition. It’s an extension of previous studies, meaning it continues to observe people who have already started the treatment.

نظرة سريعة

الحالة
نشط غير مجند
المرحلة
المرحلة 3
الراعي
يو سي بي بيوفارما إس آر إل
الهدف من التسجيل
200
ابدأ
23 Dec 2019
التاريخ المتوقع للانتهاء
27 Jul 2026

ما هو موضوع هذه الدراسة؟

This study, known as RAISE-XT, is designed for people who have generalized myasthenia gravis (gMG) and have already taken part in a previous study testing a medicine called zilucoplan. Generalized myasthenia gravis is a condition that causes muscle weakness in different parts of the body, which can make everyday tasks difficult. Zilucoplan is a new treatment being investigated for this condition. The earlier studies looked at how zilucoplan worked over a shorter period.

This new study is an 'open-label extension', which means that participants and the study team will know that everyone involved is receiving zilucoplan. It's about seeing how the medicine works and if it's safe when used for a longer time. By continuing to gather information from people who have already tried zilucoplan, researchers hope to get a clearer picture of its long-term benefits and any side effects.

The main aim is to understand if zilucoplan can help manage gMG symptoms effectively over many months or even years, and if it continues to be a safe treatment option. This kind of long-term study is very important because it helps doctors and patients make informed decisions about treatments for chronic conditions like gMG, ultimately aiming to improve quality of life.

النقاط الرئيسية

  • This study is for long-term follow-up of zilucoplan.
  • It's for people with generalized myasthenia gravis.
  • You must have been in a previous zilucoplan study.
  • The goal is to check long-term safety and how well it works.
  • You'll be closely monitored by doctors.
  • يمكنك التوقف عن المشاركة في أي وقت.

من قد يكون مؤهلاً؟

This study is specifically for adults who have already taken part in a study for zilucoplan, a medicine being tested for generalized myasthenia gravis. If you've been in one of those previous zilucoplan studies, you might be able to join this one.

You cannot join this study if you are currently taking part in another clinical trial where you are receiving an experimental treatment. This is to make sure that any effects seen are clearly due to zilucoplan and not another new medicine. However, you can still be in studies that are just observing health or collecting information, as long as they don't involve new medicines.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. I have generalized myasthenia gravis.
  2. I have already participated in an earlier study for zilucoplan.
  3. عمري 18 عامًا أو أكثر.
  4. I am not currently taking part in another study testing a new experimental medicine.
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

If you decide to join this study, you will continue to receive the medicine zilucoplan. The study team will regularly check your health, how your generalized myasthenia gravis symptoms are doing, and if you have any side effects. This will involve regular visits to the study clinic, where you might have physical exams, blood tests, and answer questions about your well-being. The exact number and frequency of visits, as well as the total length of your participation, will be clearly explained by the study team. They will continue to monitor your progress over an extended period to understand the long-term effects of zilucoplan.

المخاطر والفوائد المحتملة

Taking part in this study may offer potential benefits, such as continuing to receive a medicine that might help manage your generalized myasthenia gravis symptoms. You will also be closely monitored by a healthcare team. However, as with any medicine, there's always a chance of side effects, which the study team will discuss with you. Any new medicine also carries unknown risks, which is why studies like this are important. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (70)

  • Mg0011 41
    الرمز البريدي المؤكد
    Mobile, United States
  • Mg0011 116
    الرمز البريدي المؤكد
    فينيكس، الولايات المتحدة
  • Mg0011 31
    الرمز البريدي المؤكد
    إرفاين، الولايات المتحدة
  • MG0011 4
    الرمز البريدي المؤكد
    لوس أنجلوس، الولايات المتحدة
  • Mg0011 220
    الرمز البريدي المؤكد
    باسادينا، الولايات المتحدة
  • Mg0011 160
    الرمز البريدي المؤكد
    سان فرانسيسكو، الولايات المتحدة
  • Mg0011 24
    الرمز البريدي المؤكد
    نيو هيفن، الولايات المتحدة
  • Mg0011 27
    الرمز البريدي المؤكد
    واشنطن العاصمة، الولايات المتحدة
  • Mg0011 25
    الرمز البريدي المؤكد
    تامبا، الولايات المتحدة
  • Mg0011 135
    الرمز البريدي المؤكد
    أوغوستا، الولايات المتحدة
  • Mg0011 188
    الرمز البريدي المؤكد
    جلينفيو، الولايات المتحدة
  • Mg0011 156
    الرمز البريدي المؤكد
    إنديانابوليس، الولايات المتحدة

أسئلة شائعة

What is 'open-label'?

Open-label means that everyone involved, including you and the study doctors, knows that you are receiving the study medicine, zilucoplan.

Who is zilucoplan for?

Zilucoplan is a medicine being studied for people who have generalized myasthenia gravis, a condition causing muscle weakness.

Can I join if I'm on another new medicine?

No, you cannot join if you are currently taking part in another study that tests an experimental treatment.

What does a 'Phase 3' study mean?

Phase 3 is usually one of the final steps in testing a new medicine, looking at its effectiveness and safety in a larger group of people before it might become widely available.

ماذا يحدث بعد انتهاء الدراسة؟

The study team will explain what medical care options are available to you once your participation in the study is complete.

كيفية معرفة المزيد

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.